Our mission is to develop clinical assays for better lead compound development and monitoring patients with hemostatic, oncologic, or infectious diseases.

Invitrox will expand its revenue stream as a diagnostics company based on a portfolio of clinical assays that use a laser Doppler technique to identify and characterize suspended particles, e.g., platelets, circulating tumor cells, nanoparticles, and microbes.  Invitrox will serve as a reference lab to pharmaceutical and biotechnology companies for clinical studies with an initial focus on its optimized assays for platelet function testing and anti-coagulant drug assessment.

    Terms of Use     Privacy Policy     ¬©Copyright 2010     Site Map